<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cerebrovascular disease and <z:mp ids='MP_0002842'>high blood pressure</z:mp> both appear to increase the risk of vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>PROGRESS aims to investigate whether blood pressure lowering with an angiotensin coverting <z:chebi fb="0" ids="23924">enzyme inhibitor</z:chebi>-based regimen will reduce the risk of <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> in patients with a history of <z:hpo ids='HP_0001297'>stroke</z:hpo> or <z:e sem="disease" ids="C0007787" disease_type="Disease or Syndrome" abbrv="tia|TIA|T.I.A.">transient ischaemic attack</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>A total of at least 6000 patients will be randomised to receive <z:chebi fb="0" ids="8024">perindopril</z:chebi> (+/- indapamide) or matching placebo(s), with treatment and follow-up scheduled to continue for at least 4 years </plain></SENT>
<SENT sid="3" pm="."><plain>Substudies will investigate the effects of treatment on <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> in subgroups defined by apo-E genotype and on white matter lesions assessed by magnetic resonance imaging </plain></SENT>
<SENT sid="4" pm="."><plain>Final results from the study should be available in 2001 </plain></SENT>
</text></document>